Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TMC5 |
| Upstream (Parents) |
|---|
| (<<) TSPAN8 → TMC5 |
| (<<) MUC13 → TMC5 |
| (<<) CKMT1A///CKMT1B → TMC5 |
| (<<) PLS1 → TMC5 |
| (<<) FUT2 → TMC5 |
| Downstream (Children) |
|---|
| TMC5 → KLK1 (>>) |
| TMC5 → CYB5B (>>) |
| TMC5 → PLA2G10 (>>) |
| TMC5 → REG1B (>>) |
| TMC5 → LCN2 (>>) |
| TMC5 → PYGB (>>) |
| TMC5 → DNASE1 (>>) |
| TMC5 → SULT1C2 (>>) |
| TMC5 → HTR1D (>>) |
| TMC5 → PDZK1IP1 (>>) |
| TMC5 → SLC5A1 (>>) |
| TMC5 → FADS1 (>>) |
| TMC5 → TRPV6 (>>) |
| TMC5 → PRSS2 (>>) |
| TMC5 → CASP10 (>>) |
| TMC5 → FADS2 (>>) |
| TMC5 → BTC (>>) |
| TMC5 → LASS6 (>>) |
